Efficacy of Formulated Posterior Sub Tenon Triamcinolone in Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusions
Status:
Completed
Trial end date:
2022-03-30
Target enrollment:
Participant gender:
Summary
Retinal vein occlusion (RVO) is considered the second vascular disorder of the retina after
diabetic retinopathy. Patients with RVO are at risk of the development of macular edema.
Different treatment modalities for macular edema include LASER therapy, antivascular
endothelial growth factor (VEGF), and triamcinolone.
Aim To detect the efficacy of formulated Triamcinolone Acetonide(TA) injection in the
posterior subtenon space to manage macular edema secondary to non-ischemic RVOs, either
central or branch.